PetMed Express, Inc. (PETS)
| Market Cap | 48.73M -33.0% |
| Revenue (ttm) | 186.96M -20.7% |
| Net Income | -64.87M |
| EPS | -3.12 |
| Shares Out | 21.37M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 59,638 |
| Open | 2.290 |
| Previous Close | 2.300 |
| Day's Range | 2.270 - 2.340 |
| 52-Week Range | 1.570 - 4.320 |
| Beta | 0.79 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 9, 2026 |
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthri... [Read more]
Financial Performance
In fiscal year 2025, PetMed Express's revenue was $226.97 million, a decrease of -17.19% compared to the previous year's $274.10 million. Losses were -$6.27 million, -15.98% less than in 2024.
Financial StatementsNews
PetMed Express partners with Rural King on pet pharmacy offering
PetMed Express (PETS) announced a strategic partnership with Rural King to launch a new pet pharmacy offering, expanding access to prescription medications, preventatives and pet health products for c...
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
Collaboration expands access to affordable pet medications for rural communities nationwide Collaboration expands access to affordable pet medications for rural communities nationwide
PetMed Express, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express , Inc. , (“ PetMed " or the "Company") ( NASDAQ : PETS) investors that the firm has initiated an investigat...
Cardone Ventures announces $4.25 per share proposal to acquire PetMed Express
Cardone Ventures submitted an unsolicited, non-binding proposal to acquire PetMed Express (PETS) for $4.25 per share in cash, representing an implied equity value of approximately $89M. The proposal w...
Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express
MIAMI--(BUSINESS WIRE)--Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-...
Why Did Penny Stock PetMed Express (PETS) Soar over 68%?
Shares in PetMed Express ($PETS), an American online pet pharmacy, closed Thursday’s trading 68.36% higher following an $84 million acquisition offer from SilverCape Investments. The Singapore-based i...
PetMed Express to ‘carefully review’ SilverCape’s acquisition proposal
PetMed Express (PETS) received an unsolicited and non-binding acquisition proposal from SilverCape Investments to acquire all of the outstanding shares of the Company for $4 per share in cash, subject
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today confirmed that it has rece...
PetMed Express announces Holiday Collection
PetMed Express (PETS), d/b/a PetMeds and parent company of PetCareRx, unveiled its new Holiday Collection. “With more pet parents treating their furry friends like true members of the family, holiday
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a ...
PetMeds Extends Existing Shareholder Rights Plan
DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (...
Pets At Home's Shares Purr As Retailer Avoids Fresh Profit Warning
Despite news of further weak trading, Pets at Home's share price spiked on Wednesday as the retailer averted another confidence-crushing profit warning.
PetMed Express reports preliminary Q2 revenue $43.4M-$44.5M
For the fiscal second quarter ended September 30, 2025, net sales are estimated to range from $43.4 million to $44.5 million compared to $58.0 million in the prior year period.
PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq
DELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter fis...
PETMED EXPRESS INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
PetMed Express appoints James LaCamp to board of directors
PetMed Express (PETS) announced the appointment, effective immediately, of James LaCamp to the Company’s Board of Directors, and effective October 30, Mr. LaCamp will become Chair of the Audit Committ...
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEW...
PETMED REMINDER: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
PetMeds® Files Form 10-K for Fiscal 2025
DELRAY BEACH, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today filed with the Securities and Exchange Commi...
PetMed Express (PETS) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman
SAN FRANCISCO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company anno...
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS), today announced that on September 9, 2025, the Co...
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
PetMed Express CEO Sandra Campos, CFO Robyn D’Elia resign
PetMed Express (PETS) announced that its CEO, Sandra Campos, and CFO, Robyn D’Elia, have resigned from their positions and employment with the company. As part of the leadership changes, Leslie
PetMed Express, Inc. Announces Management Changes
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, ...
PetMed Express receives non-compliance notice from Nasdaq
PetMed Express (PETS) received on July 2, an expected notice from The Nasdaq Stock Market indicating that, as a result of not having timely filed its Annual Report on Form